http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 23 Jul 2026 00:10:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html <p>MELBOURNE, Australia and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce, effective 1 January 2027, concurrent with the relocation of its corporate headquarters to the United States.</p> <p>&quot;We have long contemplated a U.S. listing and concluded that the Company has reached a stage of maturity sufficient to attract the attention of U.S. investors,” said Mr Lachlan Hay, CLINUVEL’s Chief Operating Officer. “Based on feedback from recent non-deal roadshows, CLINUVEL&apos;s profile is seen as distinct from many http://www.streetinsider.com/Press+Releases/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html Thu, 23 Jul 2026 00:10:00 -0400 CLVLY CUV CUVL O.00706064 UR9 UR9 http://www.streetinsider.com/Press+Releases/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html <p>MELBOURNE, Australia and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce, effective 1 January 2027, concurrent with the relocation of its corporate headquarters to the United States.</p> <p>&quot;We have long contemplated a U.S. listing and concluded that the Company has reached a stage of maturity sufficient to attract the attention of U.S. investors,” said Mr Lachlan Hay, CLINUVEL’s Chief Operating Officer. “Based on feedback from recent non-deal roadshows, CLINUVEL&apos;s profile is seen as distinct from many http://www.streetinsider.com/Press+Releases/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html Thu, 23 Jul 2026 00:10:00 -0400 CLVLY CUV CUVL O.00706064 UR9 UR9 http://www.streetinsider.com/Press+Releases/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html <p>MELBOURNE, Australia and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce, effective 1 January 2027, concurrent with the relocation of its corporate headquarters to the United States.</p> <p>&quot;We have long contemplated a U.S. listing and concluded that the Company has reached a stage of maturity sufficient to attract the attention of U.S. investors,” said Mr Lachlan Hay, CLINUVEL’s Chief Operating Officer. “Based on feedback from recent non-deal roadshows, CLINUVEL&apos;s profile is seen as distinct from many http://www.streetinsider.com/Press+Releases/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html Thu, 23 Jul 2026 00:10:00 -0400 CLVLY CUV CUVL O.00706064 UR9 UR9 http://www.streetinsider.com/Press+Releases/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html <p>MELBOURNE, Australia and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce, effective 1 January 2027, concurrent with the relocation of its corporate headquarters to the United States.</p> <p>&quot;We have long contemplated a U.S. listing and concluded that the Company has reached a stage of maturity sufficient to attract the attention of U.S. investors,” said Mr Lachlan Hay, CLINUVEL’s Chief Operating Officer. “Based on feedback from recent non-deal roadshows, CLINUVEL&apos;s profile is seen as distinct from many http://www.streetinsider.com/Press+Releases/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html Thu, 23 Jul 2026 00:10:00 -0400 CLVLY CUV CUVL O.00706064 UR9 UR9 http://www.streetinsider.com/Press+Releases/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html <p>MELBOURNE, Australia and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce, effective 1 January 2027, concurrent with the relocation of its corporate headquarters to the United States.</p> <p>&quot;We have long contemplated a U.S. listing and concluded that the Company has reached a stage of maturity sufficient to attract the attention of U.S. investors,” said Mr Lachlan Hay, CLINUVEL’s Chief Operating Officer. “Based on feedback from recent non-deal roadshows, CLINUVEL&apos;s profile is seen as distinct from many http://www.streetinsider.com/Press+Releases/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html Thu, 23 Jul 2026 00:10:00 -0400 CLVLY CUV CUVL O.00706064 UR9 UR9 http://www.streetinsider.com/Press+Releases/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html <p>MELBOURNE, Australia and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce, effective 1 January 2027, concurrent with the relocation of its corporate headquarters to the United States.</p> <p>&quot;We have long contemplated a U.S. listing and concluded that the Company has reached a stage of maturity sufficient to attract the attention of U.S. investors,” said Mr Lachlan Hay, CLINUVEL’s Chief Operating Officer. “Based on feedback from recent non-deal roadshows, CLINUVEL&apos;s profile is seen as distinct from many http://www.streetinsider.com/Press+Releases/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html Thu, 23 Jul 2026 00:10:00 -0400 CLVLY CUV CUVL O.00706064 UR9 UR9 http://www.streetinsider.com/Globe+Newswire/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html <p>MELBOURNE, Australia and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce, effective 1 January 2027, concurrent with the relocation of its corporate headquarters to the United States.</p> <p>&quot;We have long contemplated a U.S. listing and concluded that the Company has reached a stage of maturity sufficient to attract the attention of U.S. investors,” said Mr Lachlan Hay, CLINUVEL’s Chief Operating Officer. “Based on feedback from recent non-deal roadshows, CLINUVEL&apos;s profile is seen as distinct from many http://www.streetinsider.com/Globe+Newswire/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html Thu, 23 Jul 2026 00:10:00 -0400 CLVLY CUV CUVL O.00706064 UR9 UR9 http://www.streetinsider.com/Globe+Newswire/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html <p>MELBOURNE, Australia and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce, effective 1 January 2027, concurrent with the relocation of its corporate headquarters to the United States.</p> <p>&quot;We have long contemplated a U.S. listing and concluded that the Company has reached a stage of maturity sufficient to attract the attention of U.S. investors,” said Mr Lachlan Hay, CLINUVEL’s Chief Operating Officer. “Based on feedback from recent non-deal roadshows, CLINUVEL&apos;s profile is seen as distinct from many http://www.streetinsider.com/Globe+Newswire/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html Thu, 23 Jul 2026 00:10:00 -0400 CLVLY CUV CUVL O.00706064 UR9 UR9 http://www.streetinsider.com/Globe+Newswire/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html <p>MELBOURNE, Australia and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce, effective 1 January 2027, concurrent with the relocation of its corporate headquarters to the United States.</p> <p>&quot;We have long contemplated a U.S. listing and concluded that the Company has reached a stage of maturity sufficient to attract the attention of U.S. investors,” said Mr Lachlan Hay, CLINUVEL’s Chief Operating Officer. “Based on feedback from recent non-deal roadshows, CLINUVEL&apos;s profile is seen as distinct from many http://www.streetinsider.com/Globe+Newswire/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html Thu, 23 Jul 2026 00:10:00 -0400 CLVLY CUV CUVL O.00706064 UR9 UR9 http://www.streetinsider.com/Globe+Newswire/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html <p>MELBOURNE, Australia and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce, effective 1 January 2027, concurrent with the relocation of its corporate headquarters to the United States.</p> <p>&quot;We have long contemplated a U.S. listing and concluded that the Company has reached a stage of maturity sufficient to attract the attention of U.S. investors,” said Mr Lachlan Hay, CLINUVEL’s Chief Operating Officer. “Based on feedback from recent non-deal roadshows, CLINUVEL&apos;s profile is seen as distinct from many http://www.streetinsider.com/Globe+Newswire/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html Thu, 23 Jul 2026 00:10:00 -0400 CLVLY CUV CUVL O.00706064 UR9 UR9 http://www.streetinsider.com/Globe+Newswire/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html <p>MELBOURNE, Australia and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce, effective 1 January 2027, concurrent with the relocation of its corporate headquarters to the United States.</p> <p>&quot;We have long contemplated a U.S. listing and concluded that the Company has reached a stage of maturity sufficient to attract the attention of U.S. investors,” said Mr Lachlan Hay, CLINUVEL’s Chief Operating Officer. “Based on feedback from recent non-deal roadshows, CLINUVEL&apos;s profile is seen as distinct from many http://www.streetinsider.com/Globe+Newswire/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html Thu, 23 Jul 2026 00:10:00 -0400 CLVLY CUV CUVL O.00706064 UR9 UR9 http://www.streetinsider.com/Globe+Newswire/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html <p>MELBOURNE, Australia and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce, effective 1 January 2027, concurrent with the relocation of its corporate headquarters to the United States.</p> <p>&quot;We have long contemplated a U.S. listing and concluded that the Company has reached a stage of maturity sufficient to attract the attention of U.S. investors,” said Mr Lachlan Hay, CLINUVEL’s Chief Operating Officer. “Based on feedback from recent non-deal roadshows, CLINUVEL&apos;s profile is seen as distinct from many http://www.streetinsider.com/Globe+Newswire/CLINUVEL+implements+strategic+reorganisation+to+refocus+on+U.S.+markets/26803078.html Thu, 23 Jul 2026 00:10:00 -0400 CLVLY CUV CUVL O.00706064 UR9 UR9 http://www.streetinsider.com/Press+Releases/CLINUVEL%E2%80%99s+ADS+to+commence+trading+on+Nasdaq/26785873.html <p align="left">MELBOURNE, Australia and NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD today announced that its American Depositary Share (ADS) is expected to commence trading on the Nasdaq Stock Market (Nasdaq) later today (New York time) under the ticker symbol CUVL. The announcement follows the declaration from the U.S. Securities and Exchange Commission (SEC) on 17 July that the Company’s publicly filed 20-F Registration Statement is deemed effective, and approval received from Nasdaq to list the ADS.</p> <p><strong>ADR uplift to Nasdaq</strong></p> <p>CLINUVEL is now in compliance with more stringent U.S. reporting requirements and http://www.streetinsider.com/Press+Releases/CLINUVEL%E2%80%99s+ADS+to+commence+trading+on+Nasdaq/26785873.html Mon, 20 Jul 2026 01:37:00 -0400 CLVLY CUV CUVL O.00706064 UR9 UR9 http://www.streetinsider.com/Press+Releases/CLINUVEL%E2%80%99s+ADS+to+commence+trading+on+Nasdaq/26785873.html <p align="left">MELBOURNE, Australia and NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD today announced that its American Depositary Share (ADS) is expected to commence trading on the Nasdaq Stock Market (Nasdaq) later today (New York time) under the ticker symbol CUVL. The announcement follows the declaration from the U.S. Securities and Exchange Commission (SEC) on 17 July that the Company’s publicly filed 20-F Registration Statement is deemed effective, and approval received from Nasdaq to list the ADS.</p> <p><strong>ADR uplift to Nasdaq</strong></p> <p>CLINUVEL is now in compliance with more stringent U.S. reporting requirements and http://www.streetinsider.com/Press+Releases/CLINUVEL%E2%80%99s+ADS+to+commence+trading+on+Nasdaq/26785873.html Mon, 20 Jul 2026 01:37:00 -0400 CLVLY CUV CUVL O.00706064 UR9 UR9 http://www.streetinsider.com/Press+Releases/CLINUVEL%E2%80%99s+ADS+to+commence+trading+on+Nasdaq/26785873.html <p align="left">MELBOURNE, Australia and NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD today announced that its American Depositary Share (ADS) is expected to commence trading on the Nasdaq Stock Market (Nasdaq) later today (New York time) under the ticker symbol CUVL. The announcement follows the declaration from the U.S. Securities and Exchange Commission (SEC) on 17 July that the Company’s publicly filed 20-F Registration Statement is deemed effective, and approval received from Nasdaq to list the ADS.</p> <p><strong>ADR uplift to Nasdaq</strong></p> <p>CLINUVEL is now in compliance with more stringent U.S. reporting requirements and http://www.streetinsider.com/Press+Releases/CLINUVEL%E2%80%99s+ADS+to+commence+trading+on+Nasdaq/26785873.html Mon, 20 Jul 2026 01:37:00 -0400 CLVLY CUV CUVL O.00706064 UR9 UR9 http://www.streetinsider.com/Press+Releases/CLINUVEL%E2%80%99s+ADS+to+commence+trading+on+Nasdaq/26785873.html <p align="left">MELBOURNE, Australia and NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD today announced that its American Depositary Share (ADS) is expected to commence trading on the Nasdaq Stock Market (Nasdaq) later today (New York time) under the ticker symbol CUVL. The announcement follows the declaration from the U.S. Securities and Exchange Commission (SEC) on 17 July that the Company’s publicly filed 20-F Registration Statement is deemed effective, and approval received from Nasdaq to list the ADS.</p> <p><strong>ADR uplift to Nasdaq</strong></p> <p>CLINUVEL is now in compliance with more stringent U.S. reporting requirements and http://www.streetinsider.com/Press+Releases/CLINUVEL%E2%80%99s+ADS+to+commence+trading+on+Nasdaq/26785873.html Mon, 20 Jul 2026 01:37:00 -0400 CLVLY CUV CUVL O.00706064 UR9 UR9 http://www.streetinsider.com/Press+Releases/CLINUVEL%E2%80%99s+ADS+to+commence+trading+on+Nasdaq/26785873.html <p align="left">MELBOURNE, Australia and NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD today announced that its American Depositary Share (ADS) is expected to commence trading on the Nasdaq Stock Market (Nasdaq) later today (New York time) under the ticker symbol CUVL. The announcement follows the declaration from the U.S. Securities and Exchange Commission (SEC) on 17 July that the Company’s publicly filed 20-F Registration Statement is deemed effective, and approval received from Nasdaq to list the ADS.</p> <p><strong>ADR uplift to Nasdaq</strong></p> <p>CLINUVEL is now in compliance with more stringent U.S. reporting requirements and http://www.streetinsider.com/Press+Releases/CLINUVEL%E2%80%99s+ADS+to+commence+trading+on+Nasdaq/26785873.html Mon, 20 Jul 2026 01:37:00 -0400 CLVLY CUV CUVL O.00706064 UR9 UR9 http://www.streetinsider.com/Press+Releases/CLINUVEL%E2%80%99s+ADS+to+commence+trading+on+Nasdaq/26785873.html <p align="left">MELBOURNE, Australia and NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD today announced that its American Depositary Share (ADS) is expected to commence trading on the Nasdaq Stock Market (Nasdaq) later today (New York time) under the ticker symbol CUVL. The announcement follows the declaration from the U.S. Securities and Exchange Commission (SEC) on 17 July that the Company’s publicly filed 20-F Registration Statement is deemed effective, and approval received from Nasdaq to list the ADS.</p> <p><strong>ADR uplift to Nasdaq</strong></p> <p>CLINUVEL is now in compliance with more stringent U.S. reporting requirements and http://www.streetinsider.com/Press+Releases/CLINUVEL%E2%80%99s+ADS+to+commence+trading+on+Nasdaq/26785873.html Mon, 20 Jul 2026 01:37:00 -0400 CLVLY CUV CUVL O.00706064 UR9 UR9 http://www.streetinsider.com/Globe+Newswire/CLINUVEL%E2%80%99s+ADS+to+commence+trading+on+Nasdaq/26785873.html <p align="left">MELBOURNE, Australia and NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD today announced that its American Depositary Share (ADS) is expected to commence trading on the Nasdaq Stock Market (Nasdaq) later today (New York time) under the ticker symbol CUVL. The announcement follows the declaration from the U.S. Securities and Exchange Commission (SEC) on 17 July that the Company’s publicly filed 20-F Registration Statement is deemed effective, and approval received from Nasdaq to list the ADS.</p> <p><strong>ADR uplift to Nasdaq</strong></p> <p>CLINUVEL is now in compliance with more stringent U.S. reporting requirements and http://www.streetinsider.com/Globe+Newswire/CLINUVEL%E2%80%99s+ADS+to+commence+trading+on+Nasdaq/26785873.html Mon, 20 Jul 2026 01:37:00 -0400 CLVLY CUV CUVL O.00706064 UR9 UR9 http://www.streetinsider.com/Globe+Newswire/CLINUVEL%E2%80%99s+ADS+to+commence+trading+on+Nasdaq/26785873.html <p align="left">MELBOURNE, Australia and NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD today announced that its American Depositary Share (ADS) is expected to commence trading on the Nasdaq Stock Market (Nasdaq) later today (New York time) under the ticker symbol CUVL. The announcement follows the declaration from the U.S. Securities and Exchange Commission (SEC) on 17 July that the Company’s publicly filed 20-F Registration Statement is deemed effective, and approval received from Nasdaq to list the ADS.</p> <p><strong>ADR uplift to Nasdaq</strong></p> <p>CLINUVEL is now in compliance with more stringent U.S. reporting requirements and http://www.streetinsider.com/Globe+Newswire/CLINUVEL%E2%80%99s+ADS+to+commence+trading+on+Nasdaq/26785873.html Mon, 20 Jul 2026 01:37:00 -0400 CLVLY CUV CUVL O.00706064 UR9 UR9 http://www.streetinsider.com/Globe+Newswire/CLINUVEL%E2%80%99s+ADS+to+commence+trading+on+Nasdaq/26785873.html <p align="left">MELBOURNE, Australia and NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD today announced that its American Depositary Share (ADS) is expected to commence trading on the Nasdaq Stock Market (Nasdaq) later today (New York time) under the ticker symbol CUVL. The announcement follows the declaration from the U.S. Securities and Exchange Commission (SEC) on 17 July that the Company’s publicly filed 20-F Registration Statement is deemed effective, and approval received from Nasdaq to list the ADS.</p> <p><strong>ADR uplift to Nasdaq</strong></p> <p>CLINUVEL is now in compliance with more stringent U.S. reporting requirements and http://www.streetinsider.com/Globe+Newswire/CLINUVEL%E2%80%99s+ADS+to+commence+trading+on+Nasdaq/26785873.html Mon, 20 Jul 2026 01:37:00 -0400 CLVLY CUV CUVL O.00706064 UR9 UR9 http://www.streetinsider.com/Globe+Newswire/CLINUVEL%E2%80%99s+ADS+to+commence+trading+on+Nasdaq/26785873.html <p align="left">MELBOURNE, Australia and NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD today announced that its American Depositary Share (ADS) is expected to commence trading on the Nasdaq Stock Market (Nasdaq) later today (New York time) under the ticker symbol CUVL. The announcement follows the declaration from the U.S. Securities and Exchange Commission (SEC) on 17 July that the Company’s publicly filed 20-F Registration Statement is deemed effective, and approval received from Nasdaq to list the ADS.</p> <p><strong>ADR uplift to Nasdaq</strong></p> <p>CLINUVEL is now in compliance with more stringent U.S. reporting requirements and http://www.streetinsider.com/Globe+Newswire/CLINUVEL%E2%80%99s+ADS+to+commence+trading+on+Nasdaq/26785873.html Mon, 20 Jul 2026 01:37:00 -0400 CLVLY CUV CUVL O.00706064 UR9 UR9 http://www.streetinsider.com/Globe+Newswire/CLINUVEL%E2%80%99s+ADS+to+commence+trading+on+Nasdaq/26785873.html <p align="left">MELBOURNE, Australia and NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD today announced that its American Depositary Share (ADS) is expected to commence trading on the Nasdaq Stock Market (Nasdaq) later today (New York time) under the ticker symbol CUVL. The announcement follows the declaration from the U.S. Securities and Exchange Commission (SEC) on 17 July that the Company’s publicly filed 20-F Registration Statement is deemed effective, and approval received from Nasdaq to list the ADS.</p> <p><strong>ADR uplift to Nasdaq</strong></p> <p>CLINUVEL is now in compliance with more stringent U.S. reporting requirements and http://www.streetinsider.com/Globe+Newswire/CLINUVEL%E2%80%99s+ADS+to+commence+trading+on+Nasdaq/26785873.html Mon, 20 Jul 2026 01:37:00 -0400 CLVLY CUV CUVL O.00706064 UR9 UR9 http://www.streetinsider.com/Globe+Newswire/CLINUVEL%E2%80%99s+ADS+to+commence+trading+on+Nasdaq/26785873.html <p align="left">MELBOURNE, Australia and NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD today announced that its American Depositary Share (ADS) is expected to commence trading on the Nasdaq Stock Market (Nasdaq) later today (New York time) under the ticker symbol CUVL. The announcement follows the declaration from the U.S. Securities and Exchange Commission (SEC) on 17 July that the Company’s publicly filed 20-F Registration Statement is deemed effective, and approval received from Nasdaq to list the ADS.</p> <p><strong>ADR uplift to Nasdaq</strong></p> <p>CLINUVEL is now in compliance with more stringent U.S. reporting requirements and http://www.streetinsider.com/Globe+Newswire/CLINUVEL%E2%80%99s+ADS+to+commence+trading+on+Nasdaq/26785873.html Mon, 20 Jul 2026 01:37:00 -0400 CLVLY CUV CUVL O.00706064 UR9 UR9 http://www.streetinsider.com/Press+Releases/SCENESSE%C2%AE+approved+for+EPP+in+Canada/26758676.html <p>MELBOURNE, Australia, July 13, 2026 (GLOBE NEWSWIRE) -- CLINUVEL’s novel drug SCENESSE® (afamelanotide) has been granted a Notice of Compliance (NOC) by Health Canada for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).</p> <p>The NOC acknowledges the compliance of the SCENESSE® new drug submission with Section C.08.002 and C.08.005 of the Canadian Food and Drug Regulations and grants CLINUVEL the right to market SCENESSE® in Canada.</p> <p><strong>Commentary</strong></p> <p>“Health Canada has taken a long time to arrive at this positive outcome,” said Dr Dennis Wright, CLINUVEL’s Chief Scientific Officer. “Data from our global http://www.streetinsider.com/Press+Releases/SCENESSE%C2%AE+approved+for+EPP+in+Canada/26758676.html Mon, 13 Jul 2026 01:10:00 -0400 A.06822034 A.17150087 CLVLY CUV O.00706064 O.20026344 O.34929518 UR9